Variant position: 324 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 486 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human WSADLNRTLSRREKKKATDG VTLTGINQTGDQ-SLPSKPSST
Mouse WSADLNRTLSRREKKKAVDG VTLTGINQTGDQ-SGQNKPGS
Rat WSADLNRTLSRREKKKAADG VTLTGINQTGDQ-SGQNKPSS
Chicken WSADLNRTLSRREKKKASDG VTLTGINQTGDQVSQPNKHSS
Xenopus laevis WSADLNRTLSRREKKKPTDG VTLTGISQSGEQSSIQNQHSS
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 486 Protein kinase C and casein kinase substrate in neurons protein 2
1 – 362 (Microbial infection) Interaction with HCV NS5A
314 – 426 Disordered
324 – 368 Polar residues
313 – 313 Phosphoserine; by PKC
313 – 313 S -> A. Increased protein interaction with HCV NS5A.
313 – 313 S -> E. Decreased protein interaction with HCV NS5A.
No reference for the current variant in UniProtKB/Swiss-Prot.
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.